![Dawn Bell](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Dawn Bell
Direktor/Vorstandsmitglied bei STRM.Bio, Inc.
Aktive Positionen von Dawn Bell
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
STRM.Bio, Inc.
![]() STRM.Bio, Inc. BiotechnologyHealth Technology STRM.Bio, Inc. is a pre-clinical biotechnology company based in Cambridge, MA. The company's goal is to make gene therapy safe for repeat dosing and to provide a future of medicine for patients with rare diseases worldwide. The company, which was founded by Jonathan Thon and has had him as CEO since incorporation, is backed by venture capital and focuses on developing and delivering targeted gene therapies using extracellular vesicles. | Direktor/Vorstandsmitglied | 17.05.2023 | - |
Karriereverlauf von Dawn Bell
Ausbildung von Dawn Bell
University of Florida | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 3 |
Operativ
Director/Board Member | 1 |
Doctorate Degree | 1 |
Sektoral
Health Technology | 2 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
STRM.Bio, Inc.
![]() STRM.Bio, Inc. BiotechnologyHealth Technology STRM.Bio, Inc. is a pre-clinical biotechnology company based in Cambridge, MA. The company's goal is to make gene therapy safe for repeat dosing and to provide a future of medicine for patients with rare diseases worldwide. The company, which was founded by Jonathan Thon and has had him as CEO since incorporation, is backed by venture capital and focuses on developing and delivering targeted gene therapies using extracellular vesicles. | Health Technology |